DABRAFENIB (TAFINLAR) 50 MG & 75 MG CAPSULES

BRAF V600E Mutation-Positive Unresectable or Metastatic Melanoma
Tafinlar as a single agent is indicated for the treatment of patients with unresectable or metastatic melanoma.

It is also used along with trametinib to treat and prevent the return of a certain type of melanoma after surgery to remove it and any affected lymph nodes.

TAFINLAR is a medicine used to treat types of Skin cancers called melanoma, Thyroid cancers called anaplastic thyroid cancer(ATC), Lung cancers called non small cell lung cancer (NSCLC) that have spread to other parts of the body or cannot be removed by surgery.

Dabrafenib (Tafinlar) Capsules suppliers in India. Allevaire India New Delhi, INDIA.

Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.

SOURCING:

Alleviare Life Sciences connects the buyer with the supplier who can ship Dabrafenib (Tafinlar) (Cancer Treatment Medicines) to any country of the world as per the buyer’s requirement and Government regulations of the country. Dabrafenib (Tafinlar) is manufactured by GlaxoSmithKline.

Alleviare Life Sciences provides options for choosing exporter and supplier of Cancer treatment Medicines We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

The order for Dabrafenib (Tafinlar) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

BRAF V600E Mutation-Positive Unresectable or Metastatic Melanoma. TAFINLAR as a single agent is indicated for the treatment of patients with unresectable or metastatic melanoma with BRAF V600 mutation as detected by an FDA-approved test.

This indication is based on the demonstration of durable response rate.Improvement in disease-related symptoms or overall survival has not been demonstrated for TAFINLAR in combination with trametinib

It is not known if TAFINLAR is safe and effective in children.

Medicine Name: Dabrafenib
Generic Name: Tefinlar
Approval Date: November, 2013
Available as (Form & Strength): Tablets: 150mg and 300mg
Company Name: GlaxoSmithKline.